USJ Stock Overview
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
USANA Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$41.00 |
| 52 Week High | US$61.50 |
| 52 Week Low | US$39.60 |
| Beta | 0.91 |
| 1 Month Change | -6.39% |
| 3 Month Change | -8.07% |
| 1 Year Change | -32.79% |
| 3 Year Change | -44.97% |
| 5 Year Change | -44.73% |
| Change since IPO | 148.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| USJ | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 2.5% | 4.8% | 1.8% |
| 1Y | -32.8% | -2.8% | 2.2% |
Return vs Industry: USJ underperformed the German Personal Products industry which returned -2.8% over the past year.
Return vs Market: USJ underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| USJ volatility | |
|---|---|
| USJ Average Weekly Movement | 4.4% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: USJ has not had significant price volatility in the past 3 months.
Volatility Over Time: USJ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,800 | Jim Brown | www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
USANA Health Sciences, Inc. Fundamentals Summary
| USJ fundamental statistics | |
|---|---|
| Market cap | €804.36m |
| Earnings (TTM) | €59.59m |
| Revenue (TTM) | €860.41m |
13.5x
P/E Ratio0.9x
P/S RatioIs USJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USJ income statement (TTM) | |
|---|---|
| Revenue | US$921.01m |
| Cost of Revenue | US$176.69m |
| Gross Profit | US$744.32m |
| Other Expenses | US$680.53m |
| Earnings | US$63.79m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 3.32 |
| Gross Margin | 80.82% |
| Net Profit Margin | 6.93% |
| Debt/Equity Ratio | 0.2% |
How did USJ perform over the long term?
See historical performance and comparison